Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Obama signs continuing resolution. Congress approves anti-counterfeiting measure. AAMI developing device interoperability standards. More news briefs.

You may also be interested in...



Pharma Industry Gets Tough On Cargo Theft

Improved technology, monitoring, legal changes and industry efforts to secure supply chains have made a sizable impact on reducing theft of pharmaceutical products, Purdue Pharma’s Charles Forsaith says.

Pharma Industry Gets Tough On Cargo Theft

Improved technology, monitoring, legal changes and industry efforts to secure supply chains have made a sizable impact on reducing theft of pharmaceutical products, Purdue Pharma’s Charles Forsaith says.

User Fee Limbo: FDA Will Not Have Access To Extra Industry Funds At FY 2013 Start

The new fiscal year starts Oct. 1, but FDA will not be able to spend the full amount of fiscal year 2013 industry user fees as a result of an emergency spending bill, and Congress is not expected to fix the issue until after the election in November at the earliest.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031610

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel